Moderna says updated Covid vaccine was effective against highly mutated BA.2.86 variant in trial
PUBLISHED WED, SEP 6 20237:02 AM EDT Annika Kim Constantino@ANNIKAKIMC CNBC KEY POINTS Moderna’s new Covid vaccine generated a strong immune response against BA.2.86, a highly mutated omicron variant that health officials are watching closely, according to clinical trial data the biotech company released Wednesday. Moderna, Pfizer and Novavax are slated to roll out new […]